Butterfly Network IPO
Butterfly Network develops portable ultrasound devices using semiconductor technology, making medical imaging more accessible and affordable. The company's handheld Butterfly iQ device connects to smartphones and has FDA approval for multiple clinical applications. The IPO attracted investor interest due to its potential to democratize medical imaging globally.
Key Facts
| Industry | Medical Technology |
| Founded | 2011 |
| Headquarters | Guilford, CT |
| Employees | ~600 |
| Website | butterflynetwork.com |
| Funding | Public company (NYSE: BFLY). SPAC merger in 2021 at $1.5B valuation |
About Butterfly Network
Butterfly Network has revolutionized medical imaging by creating the world's first handheld, whole-body ultrasound system using semiconductor technology instead of traditional piezoelectric crystals. The Butterfly iQ device connects to smartphones and tablets, making ultrasound imaging significantly more portable and affordable than conventional machines that can cost hundreds of thousands of dollars. This breakthrough has democratized access to medical imaging, particularly in point-of-care settings, emergency medicine, and underserved regions globally.
The company went public via SPAC merger in 2021 and has since focused on expanding its software platform and AI capabilities to provide automated image analysis and clinical decision support. Butterfly's technology represents a fundamental shift in how ultrasound imaging can be deployed, moving from centralized radiology departments to the bedside, primary care clinics, and even patients' homes. The platform has gained particular traction during the COVID-19 pandemic as healthcare providers sought portable diagnostic tools to minimize patient movement and reduce infection risk.
IPO Status
Butterfly Network went public in February 2021 through a SPAC merger with Longview Acquisition Corp, trading on NYSE under the ticker BFLY. The transaction valued the company at approximately $1.5 billion. Since going public, Butterfly Network's stock performance has been volatile, reflecting broader market sentiment toward growth-stage medical device companies. The company has continued to expand its portable ultrasound platform and pursue regulatory approvals in new markets, while working toward profitability as a public company.
Competitors
Frequently Asked Questions
Does Butterfly Network have a stock?
Yes, Butterfly Network completed its IPO in February 2021 through a SPAC merger. The company has been publicly traded on the NYSE under ticker BFLY since then.
When is the Butterfly Network IPO date?
Butterfly Network already completed its IPO in February 2021. The company went public through a merger with Longview Acquisition Corp.
How can I buy Butterfly Network stock?
You can buy Butterfly Network stock through any brokerage account under the ticker symbol BFLY on the NYSE. The stock is available for purchase during regular market hours through online brokers, traditional brokerages, or investment apps.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts